Citation Impact
Citing Papers
In vivo monitoring of Ca2 + uptake into mitochondria of mouse skeletal muscle during contraction
2004
bHLH transcription factor MyoD affects myosin heavy chain expression pattern in a muscle-specific fashion
2001
High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study
2017
High-throughput muscle fiber typing from RNA sequencing data
2022 StandoutNobel
Molecular and cellular mechanisms involved in the generation of fiber diversity during myogenesis
2002
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Myosin heavy chain isoform composition and Ca 2+ transients in fibres from enzymatically dissociated murine soleus and extensor digitorum longus muscles
2009
Pancreatic cancer
2020 Standout
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Fast/Glycolytic Muscle Fiber Growth Reduces Fat Mass and Improves Metabolic Parameters in Obese Mice
2008
Myosin gene mutation correlates with anatomical changes in the human lineage
2004
PD-1/PD-L1 and immunotherapy for pancreatic cancer
2017
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial
2018
Functional Classification and Experimental Dissection of Long Noncoding RNAs
2018 Standout
Hepatocellular carcinoma
2021 Standout
A Mutation in the Myostatin Gene Increases Muscle Mass and Enhances Racing Performance in Heterozygote Dogs
2007 Standout
A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
2017
Delivery technologies for cancer immunotherapy
2019 Standout
Cancer-associated cachexia
2018 Standout
Mouse models for colorectal cancer
1999
Targeting apoptosis in cancer therapy
2020 Standout
A Micropeptide Encoded by a Putative Long Noncoding RNA Regulates Muscle Performance
2015
The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation
2004
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
2015
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
Myosin heavy chain isoforms in postnatal muscle development of mice
2003
Unique features of long non-coding RNA biogenesis and function
2015 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
2020 StandoutNobel
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
2017
Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle
2004
How culture shaped the human genome: bringing genetics and the human sciences together
2010 Standout
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
ROS and the DNA damage response in cancer
2018 Standout
Postnatal Myosin Heavy Chain Isoform Expression in Normal Mice and Mice Null for IIb or IId Myosin Heavy Chains
2001
Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H
2005
The Human Condition—A Molecular Approach
2014 StandoutNobel
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
2013
The Polycomb complex PRC2 and its mark in life
2011 StandoutNature
Abundant expression of myosin heavy-chain IIB RNA in a subset of human masseter muscle fibres
2001
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
2004
Physiology and Pathophysiology of Carnosine
2013 Standout
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency
2019
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
2004
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Combination therapy in combating cancer
2017 Standout
Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis
2019
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy
2001
Ribosome Biogenesis: Emerging Evidence for a Central Role in the Regulation of Skeletal Muscle Mass
2014 Standout
Material solutions for delivery of CRISPR/Cas-based genome editing tools: Current status and future outlook
2019
Transcriptional reprogramming and ultrastructure during atrophy and recovery of mouse soleus muscle
2004
Purα and Purβ Collaborate with Sp3 To Negatively Regulate β-Myosin Heavy Chain Gene Expression duringSkeletal Muscle Inactivity
2006
Works of Brian Lu being referenced
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
2015
Spatial and Temporal Changes in Myosin Heavy Chain Gene Expression in Skeletal Muscle Development
1999
Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population
2017
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
2016
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)
2015
Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas
2016
Growth and Muscle Defects in Mice Lacking Adult Myosin Heavy Chain Genes
1997
APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma.
2019
Myosin Heavy Chains IIa and IId Are Functionally Distinct in the Mouse
1998
A randomized phase II/III study of the anti-IGF-1R antibody MK-0646 (dalotuzumab) in combination with cetuximab (Cx) and irinotecan (Ir) in the treatment of chemorefractory metastatic colorectal cancer (mCRC) with wild-type (wt) KRAS status.
2011